A Model on the Large Scale Use of Convalescent Plasma to Treat Patients with Severe Symptoms

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Convalescent plasma treatment refers to the approach of infusing patients with plasma from patients who have recently recovered from the same disease. It appears to be a possible therapeutic option to treat patients suffering from severe or lethal infectious disorders, in which traditional therapies have failed to obtain any result. Plasma therapy may be one of the few options that are rapidly available during an outbreak of an emerging infectious disease. The population-wide use of it has been proposed and investigated by public health and medical authorities in many recent outbreaks such as Ebola and COVID-19. The implementation of such large-scale program requires the coordination of donor screening and selection, plasma collection and stockpiling, and treatment authorization and delivery. In this chapter, we introduce a delay differential equation system to model the treatment-donation-stockpile dynamics arising from the implementation of the population-wide plasma therapy during a disease outbreak. We show that this model can be applied to examine potential benefits and complication in the logistic realization of plasma therapy in large population settings.

Original languageEnglish (US)
Title of host publicationFields Institute Communications
PublisherSpringer
Pages139-151
Number of pages13
DOIs
StatePublished - 2022
Externally publishedYes

Publication series

NameFields Institute Communications
Volume85
ISSN (Print)1069-5265
ISSN (Electronic)2194-1564

ASJC Scopus subject areas

  • Mathematics(all)

Fingerprint

Dive into the research topics of 'A Model on the Large Scale Use of Convalescent Plasma to Treat Patients with Severe Symptoms'. Together they form a unique fingerprint.

Cite this